Free Trial
OTCMKTS:YMDAF

Yamada (YMDAF) Stock Price, News & Analysis

Yamada logo
$3.16 0.00 (0.00%)
As of 10/15/2025

About Yamada Stock (OTCMKTS:YMDAF)

Advanced

Key Stats

Today's Range
$3.16
$3.16
50-Day Range
$3.16
$3.16
52-Week Range
$2.80
$3.16
Volume
N/A
Average Volume
3,250 shs
Market Capitalization
N/A
P/E Ratio
0.10
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Yamada Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
6th Percentile Overall Score

YMDAF MarketRank™: 

Yamada scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Yamada.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Yamada is 0.10, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 233.20.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Yamada is 0.10, which means that it is trading at a less expensive P/E ratio than the Consumer Cyclical sector average P/E ratio of about 626.28.

  • Read more about Yamada's valuation and earnings.
  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Yamada has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Yamada has recently increased by 2,042.10%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Yamada does not currently pay a dividend.

  • Dividend Growth

    Yamada does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Yamada is 15.52%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Read more about Yamada's dividend.
  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Yamada has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Yamada has recently increased by 2,042.10%, indicating that investor sentiment is decreasing significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Yamada this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Yamada insiders have not sold or bought any company stock.

  • Percentage Held by Institutions

    Only 25.62% of the stock of Yamada is held by institutions.

  • Read more about Yamada's insider trading history.
Receive YMDAF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Yamada and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

YMDAF Stock News Headlines

Is *BSEM* Oversold??
BioStem Technologies Inc. (OTC: BSEM) is emerging as one of the most exciting MedTech stories of 2025. The company delivered record-breaking revenues in 2024 and Q1 2025, including $72.5 million in net revenue for Q1 — a 73% increase over the prior year — and six consecutive quarters of positive adjusted EBITDA. With cash reserves rising to $30.8 million and a growing patent portfolio of 58 issued and 68 pending patents, BSEM is scaling profitably while advancing its proprietary BioREtain® technology, which has shown clinically superior results for chronic, non-healing wounds. National recognition is adding to the momentum, with CEO Jason Matuszewski named EY Entrepreneur of the Year 2025 Florida Award winner, validating the leadership driving this high-growth MedTech powerhouse.tc pixel
YMDAF Yamada Holdings Co., Ltd.
Yamada Holdings Co Ltd Ordinary Shares YME
YAMADA DENKI is about to announce its earnings — here's what to expect
YAMADA DENKI earnings preview: what Wall Street is expecting
See More Headlines

YMDAF Stock Analysis - Frequently Asked Questions

Yamada's stock was trading at $2.89 on January 1st, 2025. Since then, YMDAF stock has increased by 9.3% and is now trading at $3.16.

Shares of YMDAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
10/16/2025
Next Earnings (Estimated)
11/05/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Specialty Retail
Sub-Industry
N/A
Current Symbol
OTCMKTS:YMDAF
CIK
N/A
Fax
N/A
Employees
25,284
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
0.10
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (OTCMKTS:YMDAF) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners